AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.

PRESS RELEASE: Synaptic Pharmaceutical awarded patent for the alpha adrenergic 1B and 1D receptors.

Chemical Business Newsbase

| December 19, 2000 | COPYRIGHT 2000 Elsevier Engineering Information, Inc. (Hide copyright information)Copyright

Synaptic Pharmaceutical Corp has been awarded a US patent (6,156,518) for the use of the alpha adrenergic 1B and 1D receptors to screen compounds that bind to them.

The alpha adrenergic patent estate now includes the screening claims for the 1A, 1B and 1D receptors.

Synaptic Pharmaceutical Corp is a drug discovery …

Related articles from newspapers, magazines, journals, and more
Neuroreceptor for Depression Discovered.(Synaptic Pharmaceutical Corp....
Newspaper article from: Drug Discovery & Technology News November 1, 2000 700+ words
Receptor Discovery Agreement Reached.(Kissei Pharmaceutical Company Ltd. and...
Newspaper article from: Drug Discovery & Technology News February 1, 2000 700+ words
Synaptic Pharmaceutical completes its merger with a subsidiary of H Lundbeck...
News wire article from: Asia Africa Intelligence Wire March 6, 2003 700+ words
Synaptic Pharmaceutical stockholders approve merger agreement with H Lundbeck...
News wire article from: Asia Africa Intelligence Wire February 11, 2003 700+ words
Press Release: Synaptic Pharmaceutical enters into an agreement with Ranbaxy...
News wire article from: Asia Africa Intelligence Wire July 11, 2002 700+ words
©2013 Gale, a part of Cengage Learning. All rights reserved. Contact us | Privacy policy | Terms and conditions

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily